Femke Van Bockstaele

429 total citations
9 papers, 327 citations indexed

About

Femke Van Bockstaele is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Femke Van Bockstaele has authored 9 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Immunology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Femke Van Bockstaele's work include Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (4 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Femke Van Bockstaele is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (4 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Femke Van Bockstaele collaborates with scholars based in Belgium, Netherlands and South Africa. Femke Van Bockstaele's co-authors include Jan Philippé, Bruno Verhasselt, Judith Baumeister, Josefin-Beate Holz, Hans Ulrichts, Anne Schoolmeester, Karen Silence, Ann Janssens, Fritz Offner and Katrien Verschueren and has published in prestigious journals such as Blood, Clinical Chemistry and Leukemia.

In The Last Decade

Femke Van Bockstaele

9 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Femke Van Bockstaele Belgium 7 154 139 91 89 86 9 327
S. Soto United States 4 357 2.3× 146 1.1× 90 1.0× 157 1.8× 260 3.0× 11 434
Sara Marietti Italy 10 245 1.6× 160 1.2× 102 1.1× 80 0.9× 131 1.5× 14 385
S Vauterin Belgium 12 65 0.4× 124 0.9× 58 0.6× 360 4.0× 10 0.1× 18 477
AM Gewirtz United States 12 155 1.0× 93 0.7× 103 1.1× 383 4.3× 17 0.2× 24 500
Ali Amin Asnafi Iran 10 73 0.5× 75 0.5× 69 0.8× 209 2.3× 40 0.5× 35 350
H. Yesid Estupiñán Colombia 8 206 1.3× 90 0.6× 72 0.8× 65 0.7× 138 1.6× 18 314
Maria Luigia Vigliotti Italy 10 130 0.8× 68 0.5× 49 0.5× 91 1.0× 89 1.0× 17 309
TRDJ Radstake Netherlands 10 35 0.2× 97 0.7× 43 0.5× 47 0.5× 50 0.6× 20 268
Vincent Jallu France 15 38 0.2× 42 0.3× 97 1.1× 452 5.1× 21 0.2× 32 597
PJ Newman United States 12 27 0.2× 95 0.7× 66 0.7× 746 8.4× 23 0.3× 17 833

Countries citing papers authored by Femke Van Bockstaele

Since Specialization
Citations

This map shows the geographic impact of Femke Van Bockstaele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Femke Van Bockstaele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Femke Van Bockstaele more than expected).

Fields of papers citing papers by Femke Van Bockstaele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Femke Van Bockstaele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Femke Van Bockstaele. The network helps show where Femke Van Bockstaele may publish in the future.

Co-authorship network of co-authors of Femke Van Bockstaele

This figure shows the co-authorship network connecting the top 25 collaborators of Femke Van Bockstaele. A scholar is included among the top collaborators of Femke Van Bockstaele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Femke Van Bockstaele. Femke Van Bockstaele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ulrichts, Hans, Karen Silence, Anne Schoolmeester, et al.. (2011). Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs. Blood. 118(3). 757–765. 140 indexed citations
2.
Boelens, Jerina, Sofie Lust, Femke Van Bockstaele, et al.. (2009). Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia. Leukemia Research. 33(10). 1335–1343. 13 indexed citations
3.
Kamphuisen, Pieter W., Izaak den Daas, Femke Van Bockstaele, et al.. (2009). Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Anti-Vwf Nanobody® ALX-0681 After Single and Multiple Subcutaneous Administrations to Healthy Volunteers.. Blood. 114(22). 1063–1063. 6 indexed citations
4.
Bockstaele, Femke Van, Bruno Verhasselt, & Jan Philippé. (2008). Prognostic markers in chronic lymphocytic leukemia: A comprehensive review. Blood Reviews. 23(1). 25–47. 87 indexed citations
5.
Bockstaele, Femke Van, et al.. (2007). Efficient gene transfer in CLL by mRNA electroporation. Leukemia. 22(2). 323–329. 20 indexed citations
6.
Bockstaele, Femke Van, Ann Janssens, Filip Callewaert, et al.. (2006). Kolmogorov–Smirnov statistical test for analysis of ZAP‐70 expression in B‐CLL, compared with quantitative PCR and IgVH mutation status. Cytometry Part B Clinical Cytometry. 70B(4). 302–308. 13 indexed citations
7.
Bockstaele, Femke Van, Ann Janssens, Filip Callewaert, et al.. (2006). Lipoprotein Lipase mRNA Expression in Whole Blood Is a Prognostic Marker in B Cell Chronic Lymphocytic Leukemia. Clinical Chemistry. 53(2). 204–212. 46 indexed citations
8.
Philippé, Jan, et al.. (2004). Correlation of ZAP-70 analysed by flow cytometry with IgVH mutational status in B-CLL. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
9.
Philippé, Jan, et al.. (2004). The Restricted VH-Gene Usage Is of Prognostic Value in B-Cell Chronic Lymphocytic Leukemia.. Blood. 104(11). 1911–1911. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Soto Breakdown of academic impact, for papers by Sara Marietti Breakdown of academic impact, for papers by S Vauterin Breakdown of academic impact, for papers by AM Gewirtz Breakdown of academic impact, for papers by Ali Amin Asnafi Breakdown of academic impact, for papers by H. Yesid Estupiñán Breakdown of academic impact, for papers by Maria Luigia Vigliotti Breakdown of academic impact, for papers by TRDJ Radstake Breakdown of academic impact, for papers by Vincent Jallu Breakdown of academic impact, for papers by PJ Newman
Rankless by CCL
2026